Recent Blog Articles

Heart Beat: Too soon to sell a gene test for warfarin?

February 01, 2007

Heart Beat

Too soon to sell a gene test for warfarin?

One of the frustrations of starting warfarin (Coumadin) to prevent blood clots is finding the amount that's right for you. It can take several weeks of trial and error to settle on a daily dose that inhibits your blood's clotting cascade just enough to prevent clots from forming and not so much that you bleed too easily.

The discovery that two key genes influence how quickly the body breaks down and eliminates warfarin has prompted the development of genetic tests that may — we stress the "may" — simplify the process of finding the safest warfarin dose. One company, Genelex, is already marketing a test directly to consumers that it claims will help you reach your target dosage "faster and safer."

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.